FIELD: pharmacy.
SUBSTANCE: invention relates to a compound or a pharmaceutically acceptable salt thereof, having the following structure:
The invention also relates to other individual compounds and pharmaceutically acceptable salts thereof, the structural formulas of which are indicated in the claims, a pharmaceutical composition for HIV replication inhibition and to a method for HIV infection treatment.
EFFECT: new propenoate betulin derivatives are obtained, that inhibit HIV replication.
20 cl, 2 tbl, 35 ex
Title | Year | Author | Number |
---|---|---|---|
C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | 2017 |
|
RU2716502C2 |
TRITERPENE DERIVATIVES OF LUPEOL TYPE AS ANTIVIRAL PREPARATIONS | 2010 |
|
RU2561604C2 |
METHOD OF PRODUCING BETULIN 28-HEMISUCCINATE | 2010 |
|
RU2435779C1 |
RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
SHIP1 MODULATORS AND METHODS RELATED THERETO | 2014 |
|
RU2679805C2 |
(3bR*,7aR*,10bR*,14aR*-cis-14c,14d)-2,9 BIS(HALOGENPHENYL)OCTADECAHYDRO-1H,8H-2,3a,7b,9,10a,14b-HEXAAZADIBENZO[fg,op]TETRACENES AND THEIR PRODUCTION METHOD | 2021 |
|
RU2787455C1 |
(3BR*,7AR*,10BR*,14AR*-CIS-14C,14D)-2,9-BIS(METHYLPHENYL OR METHOXYPHENYL)OCTADECAHYDRO-1H,8H-2,3A,7B,9,10A,14B-HEXAAZADIBENZO[FG,OP]TETRACENES AND METHODS OF THEIR OBTAINING | 2022 |
|
RU2788760C1 |
DERIVATIVES OF PYRROLOPYRIMIDINE USEFUL AS JAK-KINASES INHIBITORS | 2012 |
|
RU2618673C2 |
METHOD FOR OBTAINING (3BR*,7AR*,10BR*,14AR*-CIS-14C,14D)-2,9-BIS(PYRIDIN-3-YLMETHYL)OCTADECAHYDRO-1H,8H-2,3A,7B,9,10A, 14B-HEXAAZADIBENZO[FG,OP]TETRACENE AND ITS USE AS AN AGENT WITH CYTOTOXIC ACTIVITY | 2022 |
|
RU2792567C1 |
Authors
Dates
2017-03-17—Published
2012-12-14—Filed